BEAPP 4th Annual Scientific Conference on 18 March 2010, Diamant Center, Brussels

   
The Belgian Association of Pharmaceutical Physicians organizes its 4th Annual Scientific Conference at the Diamant Center in Brussels on 18MAR2010. Crossover is represented with a speaker on the program. Jean-Pierre Tassignon, Visiting Professor and Head of the Crossover Clinical Research Unit at University hospitals Brugmann (adults and maternity) and HUDERF (pediatric hospital) in Brussels will give a lecture on “Patient Recruitment: Too Difficult in Belgium?”. Jean-Pierre will indicate that Belgium is the most intensive country in terms of new clinical trials set up per million inhabitants per year. Clouds are gathering over the validity of pooling indiscriminately clinical data from any country in the world, particularly where GDP per capita is much lower than in the EU/US, where access to the standard of care available in OECD countries is not effectively available to patients outside clinical trials, where the risk of counterfeit concomitant medications is significant, where clinical trial participants have no access in practice to defend themselves in the courts, where there is little or no inspection of clinical trials by the competent authorities, etc. Hence, large hospitals in economically advanced countries with a strong clinical research tradition become the more valuable. They screen the population within the radius they serve day in day out with the most advanced technology available, and therefore identify the niche patients suitable for current hyper-selective protocols in terms of admissible patients. With a properly functioning clinical research unit, large hospitals can accommodate more trials and minimize the project management syndrome of zero-enrolling sites.

EFGCP Annual Conference on 26-27 January 2010 in Brussels 

Jean-Pierre Tassignon will open the conference and provide closing remarks. The conference is about ‘The impact of personalized medicine on society: how to tackle the new challenges’. Link

EFGCP Multidisciplinary Workshop on 7 July 2009, Diamant Center, Brussels  

This conference is about ‘A single CTA in multinational clinical trials: dream or option?’. Jean-Pierre Tassignon will co-chair the session on how a single CTA could affect Research Ethics Committee procedures.

BPCM academic meeting on 16 January 2009 in Brussels. Jean-Pierre Tassignon, who is a Fellow of the Belgian College of Pharmaceutical Medicine, will attend this meeting.